These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27943236)

  • 21. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.
    Kimball AB; Sobell JM; Zouboulis CC; Gu Y; Williams DA; Sundaram M; Teixeira HD; Jemec GB
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):989-94. PubMed ID: 26201313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrinologic Aspects of Hidradenitis Suppurativa.
    Karagiannidis I; Nikolakis G; Zouboulis CC
    Dermatol Clin; 2016 Jan; 34(1):45-9. PubMed ID: 26617357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
    Jensterle M; Pirš B; Goričar K; Dolžan V; Janež A
    Eur J Clin Pharmacol; 2015 Jul; 71(7):817-24. PubMed ID: 25991051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liraglutide: A New Option for the Treatment of Obesity.
    Nuffer WA; Trujillo JM
    Pharmacotherapy; 2015 Oct; 35(10):926-34. PubMed ID: 26497479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local wound care and topical management of hidradenitis suppurativa.
    Alavi A; Kirsner RS
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S55-61. PubMed ID: 26470618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of hidradenitis suppurativa.
    Drug Ther Bull; 2016 Sep; 54(9):102-5. PubMed ID: 27585997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Finasteride for the treatment of hidradenitis suppurativa in children and adolescents.
    Randhawa HK; Hamilton J; Pope E
    JAMA Dermatol; 2013 Jun; 149(6):732-5. PubMed ID: 23552442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hidradenitis suppurativa and Crohn's disease: two cases that support an association.
    Yazdanyar S; Miller IM; Jemec GB
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors and the cardiovascular system].
    Fiorentino TV; Sesti G
    G Ital Cardiol (Rome); 2016 Dec; 17(12 Suppl 2):13S-19. PubMed ID: 28151517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
    Diamantova D; Lomickova I; Cetkovska P
    Acta Dermatovenerol Croat; 2014; 22(4):291-3. PubMed ID: 25580790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hidradenitis suppurativa with biologic medications.
    Lee RA; Eisen DB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S82-8. PubMed ID: 26470624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycemic Control in the Treatment of Psoriasis.
    Ip W; Kirchhof MG
    Dermatology; 2017; 233(1):23-29. PubMed ID: 28538228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Not Available].
    Fischli S; Henzen C
    Ther Umsch; 2017; 74(8):433-439. PubMed ID: 29461151
    [No Abstract]   [Full Text] [Related]  

  • 36. A case series of 20 women with hidradenitis suppurativa treated with spironolactone.
    Lee A; Fischer G
    Australas J Dermatol; 2015 Aug; 56(3):192-6. PubMed ID: 26080895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The extra-glycemic effects of liraglutide: focus on cardiometabolic markers].
    Giglio RV; Patti AM; Nikolic D; Castellino G; Noto M; Parrino A; Montalto G; Rizzo M
    G Ital Cardiol (Rome); 2016 Apr; 17(4):253-8. PubMed ID: 27093208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa.
    Baerveldt EM; Kappen JH; Thio HB; van Laar JA; van Hagen PM; Prens EP
    Ann Rheum Dis; 2013 Apr; 72(4):626-7. PubMed ID: 23148307
    [No Abstract]   [Full Text] [Related]  

  • 39. [GLP-1 agonist supports weight loss].
    Weiß M
    MMW Fortschr Med; 2016 Feb; 158(2):71. PubMed ID: 26961053
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome.
    Tzotzas T; Karras SN; Katsiki N
    Curr Vasc Pharmacol; 2017; 15(3):218-229. PubMed ID: 28003008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.